is raising questions about how a cancer that is typically found early could be undiscovered so long in someone with the comprehensive medical care of a former President. Biden has Stage 4 prostate ...

A new study has highlighted a significant knowledge gap among patients about repeat radiotherapy (reirradiation) as a treatment option for recurrent prostate cancer ...

The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly ...

PSA test detects benign cancers which can result in men having radiotherapy, surgery or hormone therapy, putting them at risk ...

A landmark review of nearly 800,000 men has found that PSA blood tests do reduce prostate cancer deaths — a shift from ...

Extended follow-up data from the phase 3 study (20 months after reported topline data, median follow-up 58 months) confirmed a statistically ...

Prostate cancer is being diagnosed much later than other cancers, The Telegraph can reveal. An investigation has shown that ...

Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of ...

Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat prostate cancer in adults. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to other ...

Researchers have found a simple at home urine test for prostate cancer screening is highly accurate. Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine ...

A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.